Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse

  1. Luke Isbel
  2. Lexie Prokopuk
  3. Haoyu Wu
  4. Lucia Daxinger
  5. Harald Oey
  6. Alex Spurling
  7. Adam J Lawther
  8. Matthew W Hale
  9. Emma Whitelaw  Is a corresponding author
  1. La Trobe Institute for Molecular Science, Australia
  2. Hudson Institute of Medical Research, Australia
  3. Leiden University Medical Centre, Netherlands
  4. University of Queensland Diamantina Institute, Australia
  5. La Trobe University, Australia

Abstract

We previously identified Wiz in a mouse screen for epigenetic modifiers. Due to its known association with G9a/GLP, Wiz is generally considered a transcriptional repressor. Here we provide evidence that it may also function as a transcriptional activator. Wiz levels are high in brain but its function and direct targets are unknown. ChIP-seq was performed in adult cerebellum and Wiz peaks were found at promoters and transcription factor CTCF binding sites. RNA-seq in Wiz mutant mice identified genes differentially regulated in adult cerebellum and embryonic brain. In embryonic brain most decreased in expression and included clustered protocadherin genes. These also decreased in adult cerebellum and showed strong Wiz ChIP-seq enrichment. Because a precise pattern of protocadherin gene expression is required for neuronal development, behavioural tests were carried out on mutant mice, revealing an anxiety-like phenotype. This is the first evidence of a role for Wiz in neural function.

Data availability

The following data sets were generated
The following previously published data sets were used
    1. Bian C
    2. Chen Q
    3. Yu X
    (2015) G9a, ZNF644 and WIZ ChIP-seq results
    Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE62616).

Article and author information

Author details

  1. Luke Isbel

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5270-4347
  2. Lexie Prokopuk

    Centre for Genetic Diseases, Hudson Institute of Medical Research, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Haoyu Wu

    Department of Human Genetics, Leiden University Medical Centre, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Lucia Daxinger

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Harald Oey

    Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Alex Spurling

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4368-6191
  7. Adam J Lawther

    Department of Psychology and Counselling, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthew W Hale

    Department of Psychology and Counselling, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Emma Whitelaw

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    For correspondence
    e.whitelaw@latrobe.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2320-2903

Ethics

Animal experimentation: All animal work was conducted in accordance with the Australian code for the care and use of animals for scientific purposes, this study was approved by the Animal Ethics Committee of La Trobe University, project numbers 12-74, 12-75, 15-01.

Copyright

© 2016, Isbel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,606
    views
  • 557
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Luke Isbel
  2. Lexie Prokopuk
  3. Haoyu Wu
  4. Lucia Daxinger
  5. Harald Oey
  6. Alex Spurling
  7. Adam J Lawther
  8. Matthew W Hale
  9. Emma Whitelaw
(2016)
Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse
eLife 5:e15082.
https://doi.org/10.7554/eLife.15082

Share this article

https://doi.org/10.7554/eLife.15082

Further reading

    1. Chromosomes and Gene Expression
    2. Microbiology and Infectious Disease
    Maruti Nandan Rai, Qing Lan ... Koon Ho Wong
    Research Article Updated

    Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.

    1. Chromosomes and Gene Expression
    2. Neuroscience
    Robyn D Moir, Emilio Merheb ... Ian M Willis
    Research Article

    Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.